tion to euthyroidism by treatment was uniformly accompanied by a normalization of serum TBPA and TBG levels. A negative correlation between serum thyroid hormone binding protein (TBG and ficient of correlation between TBPA and free thyroxine was -0.80 (P<0.01) and between TBG and free thyroxine -0.58 (P<0.01). From these experiments it appears that not only TBG but also TBPA may play an important role in the regulation of the free thyro xine concentration in response to various thyroidal states.
tence of thyroxine binding prealbumin (TBPA) as one of normal constituents of gators had reported its physiological role in the peripheral metabolism of thyroxine.
In previous studies, TBPA was indirectly city of TBPA for the isotope labeled thyroxine (Ingbar and Freinkel, 1960; Oppenheimer et al., 1966) and directly mide (Sakurada et al., 1968) or starch gel electrophoresis (Surks and Oppenheimer, 1964) and by radial diffusion on cellulose acetate strips sprayed with diluted antisera (Agostoni et al., 1968 body for TBPA was always less than 15%. Thus, the crossreaction of TBG with the antibody for TBPA was negligible.
Preparation of 125I-TBPA The iodination procedure of Bolton-Hunter (The Radiochemical Center, England) was used for TBPA iodination (Bolton and Hunter, 1973 mal range in untreated hypothyroidism (Fig. 2) . When the symptoms of hyperthyroidism subsided following continuous treatment with anti-thyroid drug, the normalization of both TBPA and TBG levels was also Japon. October 1982 tically significant (P<0.01). Similarly, when the patients with hypothyroidism were treated with T4 for more than 2 months, the decrease of the TBPA and TBG levels was observed, and this change was statistically significant (P<0.05) (Fig. 4) .
TBPA, TBG and FT4 values before and after treatment with antithyroid drug were determined in 10 patients with hyperthyroidism. A negative correlation between these thyroxine-binding proteins and FT4 (Fig. 6 ). We also examined the relationship between FT4 and thyroid hormone binding protein (TBG and TBPA) in sera of hyperthyroid patients before and after therapy. The scatter diagram of serum TBG levels against FT4 levels revealed a highly significant inverse correlation. However, an even more striking inverse correlation was evident in the plot of TBPA against FT4.
The T4 binding capacity and TBG by RIA in sera of thyrotoxicosis was most often found to be normal or slightly decreased. It seemed reasonable to assume that the other major T4 binding protein, TBPA, might be play a role in increasing the serum FT4 concentration.
In previous studies it was reported that serum TBPA levels were low in malnutrition (Ingenbleek et al., 1975; Ogushina and Hussain, 1980) , liver disease (Inada and Sterling, 1967b) , acute stress (Ramsden et al., 1978) , severe illness (Helenius and Liewandahl, 1979) and cancer (Hollinshed et al., 1977; Milano et al., 1978) . The fall in the serum TBPA concentration following acute stress has been shown to be due to the reduction in the hepatic synthesis of this protein rather than the increase in catabolism or urinary excretion (Socolow et al., 1965; Oppenheimer et al., 1965) . We also reported patients with cancer with high serum TBG levels, and these patients in contrast showed low TBPA levels with slightly higher FT4 levels (Kajita et al., 1981) . However, Woeber and Ingbar (1968) reported that the Endocrinol.
Japon. October 1982 virtually complete removal of TBPA from serum does not increase %FT4 to the values observed in the sera of nonthyroid illness. Recent studies (Chopra et al., 1979; Woever and Maddux, 1981) suggested that the serum of some patients with severe nonthyroid illness interferes with T4-binding caused by either a non-ultrafiltrable binding inhibitor or a protein-protein interaction.
Recently, Black and Oatley (1977) have suggested also that TBPA has a three-dimensional structural complementarity to doublehelical DNA, suggesting that TBPA may be a model for the thyroid hormone nuclear receptor. From these viewpoints it is suggested that TBPA may play an important role in the regulation of the FT4 concentration in response to varying thyroidal states.
